Floatz logo

Piperacillin

Asthma

Chronic Obstructive Pulmonary Disease Trial Network, DenmarkSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Asthma cohort.

Asset / SponsorPhaseRating
Budesonide
New York City Health and Hospitals Corporation
Phase 4BBB
SALMETEROL
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 4BBB
Flixotide
GlaxoSmithKline
Phase 4BBB
Montelukast
Kafrelsheikh University
Phase 4BBB
Beclomethasone
New York City Health and Hospitals Corporation
Phase 4BB

View all 48 →

Same molecule, other indications

Piperacillin is also rated in:

chronic obstructive pulmonary diseaseDormant
BB
Indicative ·
65 / 100
View asset →
respiratory tract infectious disorderDormant
BB
Indicative ·
65 / 100
View asset →
Pseudomonas aeruginosa infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →